Publication:
Placement technique and the early complications of balloon breast brachytherapy - magee-womens hospital experience

dc.contributor.authorSoran, Atilla
dc.contributor.authorBeriwal, Sushil
dc.contributor.authorMogus, Robert
dc.contributor.authorKeenan, Donald
dc.contributor.authorKelley, Joseph L.
dc.contributor.authorBalkan, Mujdat
dc.contributor.authorHarlak, Ali
dc.contributor.authorBonaventura, Marguerite A.
dc.contributor.authorJohnson, Ronald
dc.contributor.authorFalk, Jeffrey S.
dc.contributor.buuauthorEvrensel, Türkkan
dc.contributor.buuauthorEVRENSEL, TÜRKKAN
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Onkoloji Anabilim Dalı.
dc.contributor.orcid0000-0002-3398-7230
dc.contributor.orcid0000-0002-9015-5617
dc.contributor.researcheridAAJ-1027-2021
dc.date.accessioned2024-09-10T05:47:15Z
dc.date.available2024-09-10T05:47:15Z
dc.date.issued2007-04-01
dc.descriptionBu çalışma, 30 Ekim- 03 Kasım 2010 tarihleri arasında Paris[Fransa]’da düzenlenen 13. Annual Meeting of the European Conference for Clinical Oncology’da bildiri olarak sunulmuştur.
dc.description.abstractBackgrounds and Objectives: Open (OT) and percutaneous closed (PCT) techniques have been described for placement of the MammoSite catheter to deliver accelerated partial breast brachytherapy. We report early complications of both techniques.Methods: A total of 125 patients underwent catheter placement for MammoSite high-dose rate brachytherapy, with 108 patients successfully completing treatment. The OT was used in 85 patients and PCT in 40 patients. The mean distance between the balloon surface and breast skin was 1.44 cm and 1.31 cm, respectively. Average skin dose was 278 cGy in the OT group and 295 cGy in the PCT group (P > 0.05). Average gross specimen size was 43.16 cm(3) in the OT group and 62.19 cm(3) in the PCT group. Median follow-up was I I months for the OT group and 5 months for the PCT group.Results: In 17 cases, the catheter was subsequently removed without the patient completing treatment. Two of the patients in the OT group (3%) developed a delayed abscess. The overall incidence of persistent seroma (>6 months) was 20% with all occurring in the OT group, 30% of those patients. There were no acute skin toxicities higher than grade 2. The overall cosmesis is excellent or good in 95% of patients.Conclusion: Despite short follow-up and a small sample size in this study, it seems that the MammoSite brachytherapy was well tolerated by patients with early stage breast cancer when using either the OT or PCT.
dc.identifier.doi10.1097/01.coc.0000255573.02106.bc
dc.identifier.endpage155
dc.identifier.issn0277-3732
dc.identifier.issue2
dc.identifier.startpage152
dc.identifier.urihttps://doi.org/10.1097/01.coc.0000255573.02106.bc
dc.identifier.urihttps://hdl.handle.net/11452/44439
dc.identifier.volume30
dc.identifier.wos000245637100008
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.journalAmerican Journal Of Clinical Oncology-cancer Clinical Trials
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectMammosite
dc.subjectIrradiation
dc.subjectApplicator
dc.subjectSurgery
dc.subjectTherapy
dc.subjectMammosite
dc.subjectBrachytherapy
dc.subjectOpen
dc.subjectClosed
dc.subjectTechnique
dc.subjectComplications
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectOncology
dc.titlePlacement technique and the early complications of balloon breast brachytherapy - magee-womens hospital experience
dc.typeArticle
dc.typeProceedings Paper
dspace.entity.typePublication
relation.isAuthorOfPublicationeceff514-6af7-4c3b-a146-b77546565a6c
relation.isAuthorOfPublication.latestForDiscoveryeceff514-6af7-4c3b-a146-b77546565a6c

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Türkkan_vd_2007.pdf
Size:
166.96 KB
Format:
Adobe Portable Document Format

Collections